Abstract
A series of highly functionalized naphthoquinones was prepared by an original tetrakis-SRN1 reaction involving 2,3,6,7-tetrakis(chloromethyl)-5,8-dimethoxynaphthalene-1,4-dione with various nitronate anions and S-centered anions.
Keywords: Naphthoquinone, tetrakis-SRN1, electron transfer reaction, nitronate anions, anthracyclines, sulfones
Letters in Organic Chemistry
Title: First Tetrakis-SRN1 Reaction in Naphthoquinone Series
Volume: 5 Issue: 1
Author(s): Patrice Vanelle, Abdelouahab Beziane, Omar Khoumeri and Thierry Terme
Affiliation:
Keywords: Naphthoquinone, tetrakis-SRN1, electron transfer reaction, nitronate anions, anthracyclines, sulfones
Abstract: A series of highly functionalized naphthoquinones was prepared by an original tetrakis-SRN1 reaction involving 2,3,6,7-tetrakis(chloromethyl)-5,8-dimethoxynaphthalene-1,4-dione with various nitronate anions and S-centered anions.
Export Options
About this article
Cite this article as:
Vanelle Patrice, Beziane Abdelouahab, Khoumeri Omar and Terme Thierry, First Tetrakis-SRN1 Reaction in Naphthoquinone Series, Letters in Organic Chemistry 2008; 5 (1) . https://dx.doi.org/10.2174/157017808783330135
DOI https://dx.doi.org/10.2174/157017808783330135 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Making the Most of Pathological Specimens: Molecular Diagnosis in Formalin-Fixed, Paraffin Embedded Tissue
Current Drug Targets Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design QSAR and Docking Studies on Different Series of Histone Deacetylase Inhibitors (HDACIs)
Letters in Drug Design & Discovery Molecular Targets of FTY720 (Fingolimod)
Current Molecular Medicine Reverse Pharmacognosy: Application of Selnergy, a New Tool for Lead Discovery. The Example of ε-Viniferin
Current Drug Discovery Technologies CycloSal-Pronucleotides of Brivudine Monophosphate - Highly Active Antiviral Agents
Current Medicinal Chemistry - Anti-Infective Agents The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis
Current Cancer Therapy Reviews Meet Our Editorial Board Member
Current Stem Cell Research & Therapy Synthetic and Biological Aspects of Thiadiazoles and their Condensed Derivatives: An Overview
Current Topics in Medicinal Chemistry Development of Novel Therapeutic Drugs in Humans from Plant Antimicrobial Peptides
Current Protein & Peptide Science MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Current Pharmacogenomics and Personalized Medicine UPA and PAI-1 Analysis from Fixed Tissues – New Perspectives for a Known Set of Predictive Markers
Current Medicinal Chemistry Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole- Containing Ruthenium Complexes
Mini-Reviews in Medicinal Chemistry Metastatic Melanoma in a Young Woman Treated with TNF-Alpha Inhibitor for Psoriatic Arthritis: A Case Report
Current Drug Safety Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance
Current Rheumatology Reviews Bortezomib as an Antitumor Agent
Current Pharmaceutical Biotechnology Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic Perspectives
Current Stem Cell Research & Therapy